Local delivery therapy of Cerebraca® Wafer being highlighted in the natural review

← Case report – Cerebraca® Wafer implantation combined with CIK therapy for the treatment of recurrent Glioblastoma revealed superior clinical outcome (overall survival extended for more than 24 months).